Research Article
Golgi Phosphoprotein 3 Represents a Novel Tumor Marker for Gastric and Colorectal Cancers
Table 3
Diagnostic efficacy of GOLPH3, CEA, and CA19-9 for GC and CRC.
| Tumor markers | Sensitivity (%) | Specificity (%) | AUC | SE | 95% CI | value |
| Gastric cancer | | | | | | | GOLPH3 | 85.3 | 80.0 | 0.881 | 0.029 | 0.824-0.939 | <0.001 | CEA | 57.8 | 92.0 | 0.858 | 0.031 | 0.796-0.919 | <0.001 | CA19-9 | 14.7 | 98.0 | 0.674 | 0.044 | 0.587-0.760 | <0.01 | Combination | 97.1 | 82.0 | 0.946 | 0.019 | 0.908-0.984 | <0.001 | Colorectal cancer | | | | | | | GOLPH3 | 83.8 | 80.0 | 0.888 | 0.024 | 0.840-0.935 | <0.001 | CEA | 44.4 | 92.0 | 0.857 | 0.034 | 0.790-0.923 | <0.001 | CA19-9 | 14.7 | 98.0 | 0.700 | 0.040 | 0.623-0.778 | <0.001 | Combination | 87.5 | 88.0 | 0.938 | 0.019 | 0.902-0.974 | <0.001 |
|
|